The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge
Open accessAbstract
Chronic organ injury leads to fibrosis and eventually organ failure. Fibrosis is characterized by excessive synthesis, remodeling, and contraction of extracellular matrix produced by myofibroblasts. Myofibroblasts are the key cells in the pathophysiology of fibrotic disorders and their differentiation can be triggered by multiple stimuli. To develop anti-fibrotic therapies, it is of paramount importance to understand the molecular basis of the signaling pathways contributing to the activation and maintenance of myofibroblasts. Several signal transduction pathways, such as transforming growth factor (TGF)-β, Wingless/Int (WNT), and more recently yes-associated protein 1 (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ) signaling, have been linked to the pathophysiology of fibrosis. Activation of the TGF-β1-induced SMAD complex results in the upregulation of genes important for myofibroblast function. Similarly, WNT-stabilized β-catenin translocates to the nucleus and initiates transcription of its target genes. YAP and TAZ are two transcriptional co-activators from the Hippo signaling pathway that also rely on nuclear translocation for their functioning. These three signal transduction pathways have little molecular similarity but do share one principle: the cytosolic/nuclear regulation of its transcriptional activators. Past research on these pathways often focused on the isolated cascades without taking other signaling pathways into account. Recent developments show that parts of these pathways converge into an intricate network that governs the activation and maintenance of the myofibroblast phenotype. In this review, we discuss the current understanding on the signal integration between the TGF-β, WNT, and YAP/TAZ pathways in the development of organ fibrosis. Taking a network-wide view on signal transduction will provide a better understanding on the complex and versatile processes that underlie the pathophysiology of fibrotic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kapoor, M., Liu, S., Shiwen, X., Huh, K., McCann, M. R., Denton, C. P., Woodgett, J. R., Abraham, D., & Leask, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35381 · Cited by 70
RetractedMassagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,128
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092 · cited 5×
“By contrast, β-catenin and YAP and TAZ are sequestered in protein complexes with E-cadherin or 14-3-3 proteins, respectively, or directly targeted for proteasomal degradation by associating with β-TrCP (60, 94, 97).”
BackgroundInfluentialFunctional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
β-catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,529
Cited by
Cellular and molecular mechanisms of skin wound healing
Peña, O. A., & Martin, P. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00715-1 · Cited by 1,655
Wound healing, fibroblast heterogeneity, and fibrosis
Talbott, H. E., Mascharak, S., Griffin, M., Wan, D. C., & Longaker, M. T. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.07.006 · Cited by 795
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Wang, X., Zheng, Z., Caviglia, J. M., Corey, K. E., Herfel, T. M., Cai, B., Masia, R., Chung, R. T., Lefkowitch, J. H., Schwabe, R. F., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.016 · Cited by 413
“…particularly in the lung with links to TGFb-SMAD signaling or induction of plasminogen activator inhibitor-1 (Liu et al., 2015; Mitani et al., 2009; Piersma et al., 2015; Saito and Nagase, 2015), there are only scattered reports about their roles in liver fibrosis and none in the setting of NAFLD.”
WNT Signaling in Cardiac and Vascular Disease
Foulquier, S., Daskalopoulos, E. P., Lluri, G., Hermans, K. C. M., Deb, A., & Blankesteijn, W. M. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.013896 · Cited by 347
Pakshir, P., Noskovicova, N., Lodyga, M., Son, D. O., Schuster, R., Goodwin, A., Karvonen, H., & Hinz, B. (2020) · Journal of Cell Science · doi:10.1242/jcs.227900 · Cited by 293
Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model
Pei, Z., Qin, Y., Fu, X., Yang, F., Huo, F., Liang, X., Wang, S., Cui, H., Lin, P., Zhou, G., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102509 · Cited by 269
Aging of the skeletal muscle extracellular matrix drives a stem cell fibrogenic conversion
Stearns-Reider, K. M., D'Amore, A., Beezhold, K., Rothrauff, B., Cavalli, L., Wagner, W. R., Vorp, D. A., Tsamis, A., Shinde, S., Zhang, C., et al. (2017) · Aging Cell · doi:10.1111/acel.12578 · Cited by 265
“…recent studies have highlighted the convergence of YAP/TAZ proteins and transforming growth factor-beta (TGF-b1) signaling pathway (reviewed in Piersma et al., 2015), we evaluated whether pharmacologic inhibition of TGF-b1, a master regulator of fibrogenesis, could reverse the effect of age…”
BackgroundKasembeli, M. M., Bharadwaj, U., Robinson, P., & Tweardy, D. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082299 · Cited by 199
Implant Fibrosis and the Underappreciated Role of Myofibroblasts in the Foreign Body Reaction
Noskovicova, N., Hinz, B., & Pakshir, P. (2021) · Cells · doi:10.3390/cells10071794 · Cited by 184
Liver regeneration requires Yap1-TGFβ-dependent epithelial-mesenchymal transition in hepatocytes
Oh, S.-H., Swiderska-Syn, M., Jewell, M. L., Premont, R. T., & Diehl, A. M. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.008 · Cited by 148
Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosis
Du, K., Maeso-Díaz, R., Oh, S. H., Wang, E., Chen, T., Pan, C., Xiang, K., Dutta, R. K., Wang, X.-F., Chi, J.-T., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000326 · Cited by 102
Fiber density modulates cell spreading in 3D interstitial matrix mimetics
Matera, D. L., Wang, W. Y., Smith, M. R., Shikanov, A., & Baker, B. M. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00141 · Cited by 75
Screening for YAP inhibitors identifies statins as modulators of fibrosis
Santos, D. M., Pantano, L., Pronzati, G., Grasberger, P., Probst, C. K., Black, K. E., Spinney, J. J., Hariri, L. P., Nichols, R., Lin, Y., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0296oc · Cited by 72
Giuliodori, A., Beffagna, G., Marchetto, G., Fornetto, C., Vanzi, F., Toppo, S., Facchinello, N., Santimaria, M., Vettori, A., Rizzo, S., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy057 · Cited by 57
Ajay, A. K., Zhao, L., Vig, S., Fujiwara, M., Thakurela, S., Jadhav, S., Cho, A., Chiu, I.-J., Ding, Y., Ramachandran, K., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110473 · Cited by 47
Long, H., Lichtnekert, J., Andrassy, J., Schraml, B. U., Romagnani, P., & Anders, H.-J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1194988 · Cited by 46
Blokland, K. E. C., Nizamoglu, M., Habibie, H., Borghuis, T., Schuliga, M., Melgert, B. N., Knight, D. A., Brandsma, C.-A., Pouwels, S. D., & Burgess, J. K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.989169 · Cited by 45
Jin, J., Wang, T., Park, W., Li, W., Kim, W., Park, S. K., & Kang, K. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218184 · Cited by 43
Milenkovic, U., Ilg, M. M., Zuccato, C., Ramazani, Y., De Ridder, D., & Albersen, M. (2019) · BJU International · doi:10.1111/bju.14638 · Cited by 38
Revealing the Potency of Growth Factors in Bovine Colostrum
Yalçıntaş, Y. M., Duman, H., López, J. M. M., Portocarrero, A. C. M., Lombardo, M., Khallouki, F., Koch, W., Bordiga, M., El-Seedi, H., Raposo, A., et al. (2024) · Nutrients · doi:10.3390/nu16142359 · Cited by 31
“Within cells, TGF-β molecules are first generated as precursor proteins [29].”
BackgroundFGF23 in chronic kidney disease: Bridging the heart and anemia
Figurek, A., Rroji, M., & Spasovski, G. (2023) · Cells · doi:10.3390/cells12040609 · Cited by 22
“provides a nice summary of the detailed crosstalk between TGF, and Wnt/β-catenin, but it is beyond the focus of this review [31].”
BackgroundGlimpses into the molecular pathogenesis of Peyronie’s disease
ten Dam, E.-J. P. M., van Driel, M. F., de Jong, I. J., Werker, P. M. N., & Bank, R. A. (2020) · The Aging Male · doi:10.1080/13685538.2019.1643311 · Cited by 15
Self-citation
Metadata
- Authors
- Piersma, B., Bank, R. A., & Boersema, M.
- Venue
- Frontiers in Medicine
- Publisher
- Frontiers Media SA
- Published
- 2015-09-03
- Volume
- 2
- Pages
- 59-59
- ISSN
- 2296-858X (ISSN-L)
- OpenAlex
- W1914659192
- Cited by
- 442
- References
- 151
- FWCI
- 14.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.